Valo Health to Participate in Piper Sandler's Spring Biotech Symposium

Valo Health, Inc (“Valo”), the tech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­­gence-pow­ered com­pute, announced that its founder and CEO, David Berry, will par­tic­i­pate in the Piper San­dler Spring Biotech Sym­po­sium, on May 3^rd in Cam­bridge, MA.